CA1248298A - Agents radioprotecteurs ayant une structure amino- thioalkyle et procede pour leur preparation - Google Patents

Agents radioprotecteurs ayant une structure amino- thioalkyle et procede pour leur preparation

Info

Publication number
CA1248298A
CA1248298A CA000456939A CA456939A CA1248298A CA 1248298 A CA1248298 A CA 1248298A CA 000456939 A CA000456939 A CA 000456939A CA 456939 A CA456939 A CA 456939A CA 1248298 A CA1248298 A CA 1248298A
Authority
CA
Canada
Prior art keywords
radical
boc
mole
compound according
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000456939A
Other languages
English (en)
French (fr)
Inventor
Joel Oiry
Jean-Louis Imbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Original Assignee
Centre National de la Recherche Scientifique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique filed Critical Centre National de la Recherche Scientifique
Application granted granted Critical
Publication of CA1248298A publication Critical patent/CA1248298A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C07F9/1651—Esters of thiophosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
CA000456939A 1983-06-22 1984-06-19 Agents radioprotecteurs ayant une structure amino- thioalkyle et procede pour leur preparation Expired CA1248298A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8310318A FR2549051B1 (fr) 1983-06-22 1983-06-22 Nouveaux agents radioprotecteurs ayant une structure amino-thioalkyle et procede pour leur preparation
FR8310318 1983-06-22

Publications (1)

Publication Number Publication Date
CA1248298A true CA1248298A (fr) 1989-01-03

Family

ID=9290052

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000456939A Expired CA1248298A (fr) 1983-06-22 1984-06-19 Agents radioprotecteurs ayant une structure amino- thioalkyle et procede pour leur preparation

Country Status (8)

Country Link
US (1) US4816482A (cg-RX-API-DMAC10.html)
EP (1) EP0131500B1 (cg-RX-API-DMAC10.html)
JP (1) JPS60501605A (cg-RX-API-DMAC10.html)
AT (1) ATE27269T1 (cg-RX-API-DMAC10.html)
CA (1) CA1248298A (cg-RX-API-DMAC10.html)
DE (1) DE3463766D1 (cg-RX-API-DMAC10.html)
FR (1) FR2549051B1 (cg-RX-API-DMAC10.html)
WO (1) WO1985000167A1 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746505A (en) * 1985-04-26 1988-05-24 President And Fellows Of Harvard College Technetium radiodiagnostic fatty acids derived from bisamide bisthiol ligands
FR2654617B1 (fr) * 1989-11-20 1993-10-08 Oreal Composition cosmetique reductrice pour permanente contenant, en tant qu'agent reducteur, de l'aletheine ou l'un de ses sels, et son utilisation dans un procede de deformation permanente des cheveux.
US5643966A (en) * 1990-07-06 1997-07-01 University Of New Mexico β-alethine as anti-tumor agent
US6245561B1 (en) 1990-07-06 2001-06-12 University Of New Mexico β-alethine use in cell culture and therapy
FR2676441B1 (fr) * 1991-05-17 1994-10-28 Oreal Nouveaux alkylamino-mercaptoalkylamides ou l'un de leurs sels cosmetiquement acceptables, et leur utilisation en tant qu'agents reducteurs, dans un procede de deformation permanente des cheveux.
WO1993016991A1 (es) * 1992-02-28 1993-09-02 Consejo Superior Investigaciones Científicas Tensioactivos cationicos que contienen en su molecula un grupo disulfuro, su procedimiento de obtencion
US5498616A (en) * 1994-11-04 1996-03-12 Cephalon, Inc. Cysteine protease and serine protease inhibitors
PT848011E (pt) 1996-12-16 2001-08-30 Staat Nl Verteg Door Min Welzi Metodo para acoplar polisacaridos a proteinas
BR0007437A (pt) 1999-01-08 2001-11-20 Procter & Gamble Composições tópicas que compreendem tióisfuncionais protegidos
US6703007B2 (en) * 1999-01-08 2004-03-09 The Procter & Gamble Company Topical compositions comprising functional nucleophiles protected by phosphorus-containing moieties
KR101579095B1 (ko) * 2008-07-16 2015-12-21 엘지전자 주식회사 세탁물 처리기기
US9468612B2 (en) 2011-10-26 2016-10-18 Seattle Children's Hospital Cysteamine in the treatment of fibrotic disease
SG10201800159QA (en) 2011-11-22 2018-02-27 Univ California Cysteamine and/or cystamine for treating ischemic injury
CN115724779B (zh) * 2021-09-01 2024-03-29 四川大学 酰胺烷二硫化合物、其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2574996A (en) * 1948-11-18 1951-11-13 Eastman Kodak Co N-(acetylmercaptoacetyl)-n'-n-butylurea
GB710216A (en) * 1952-05-12 1954-06-09 Parke Davis & Co Improvements in or relating to the production of organic disulphides

Also Published As

Publication number Publication date
WO1985000167A1 (fr) 1985-01-17
EP0131500B1 (fr) 1987-05-20
EP0131500A1 (fr) 1985-01-16
JPS60501605A (ja) 1985-09-26
US4816482A (en) 1989-03-28
JPH0523260B2 (cg-RX-API-DMAC10.html) 1993-04-02
DE3463766D1 (en) 1987-06-25
FR2549051A1 (fr) 1985-01-18
FR2549051B1 (fr) 1986-05-16
ATE27269T1 (de) 1987-06-15

Similar Documents

Publication Publication Date Title
EP0038758B1 (fr) Dérivés d'acides aminés et leur application thérapeutique
CA2174314C (en) Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
EP0131500B1 (fr) Nouveaux agents radioprotecteurs ayant une structure amino-thioalkyle et procédé pour leur préparation
JP2540534B2 (ja) オリゴペプチジルニトリル誘導体
EP0274453A2 (fr) Nouveaux composés à activité d'inhibiteurs de collagénase, procédé pour les préparer et compositions pharmaceutiques contenant ces composés
CZ108394A3 (en) Peptide ketones as interleukin-1beta converting enzyme inhibitors
EP0082088A1 (fr) Nouveaux dérivés d'aminoacides, et leur application thérapeutique
FR2550204A1 (fr) Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
GB1585061A (en) Synthesis of peptides
EP0394126B1 (fr) Composés et complexes utiles notamment en imagerie médicale
KR20040108717A (ko) 콤브레타스타틴의 제조 방법
JPS6317839B2 (cg-RX-API-DMAC10.html)
KR20090078824A (ko) 무기네산 화합물의 효과적인 제조 방법
SE452318B (sv) Aminosyror till anvendning som mellanprodukter vid framstellning av bestatiner
US5371185A (en) 1-amino thiorcyl benzimidazoyl-2-one compounds
EP0185578B1 (fr) Procédé de synthèse d'esters actifs d'acides carboxyliques, carbonates alpha-halogénés utiles pour cette synthèse et leur mode d'obtention
EP0188947B1 (fr) Peptides réduits, inhibiteurs de la sécrétion gastrique, procédé d'obtention et compositions pharmaceutiques les contenant
US20040009923A1 (en) Peptide analogs as irreversible interleukin-1beta protease inhibitors
CA1336433C (en) Method for preparing phosphinic acids used in preparing ace inhibitors and intermediates produced thereby
CA1185248A (en) Phosphinylalkanoyl amino acids
EP0562659B1 (fr) Procédé de synthèse peptidique et nouveaux intermédiaires de synthèse
HU197928B (en) Process for the production poor in racemate of peptide intermediary of hormon synthesis of gonadorelin and gonadorelin analog
Gobec et al. Synthesis of phosphono phthalimido-desmuramyldipeptide analogs
CA2015827A1 (en) Amino acid derivatives possessing renin-inhibitory activities
Röhrich et al. Substituted 1, 2-thiazetidine 1, 1-dioxides. Synthesis of (RS)-and (S)-1, 2-thiazetidine-3-acetic acid 1, 1-dioxide and its reactions with amino acids and dipeptides

Legal Events

Date Code Title Description
MKEX Expiry